Production (Stage)
BioRestorative Therapies, Inc.
BRTX
$1.66
$0.063.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.11M | 10.73M | 13.09M | 14.68M | 16.42M |
| Total Receivables | 25.00K | 188.40K | 165.00K | 27.40K | 35.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 217.40K | 223.20K | 233.70K | 295.90K | 317.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 22.40K | -- | -- |
| Total Current Assets | 9.36M | 11.14M | 13.51M | 15.00M | 16.77M |
|
|
|||||
| Total Current Assets | 9.36M | 11.14M | 13.51M | 15.00M | 16.77M |
| Net Property, Plant & Equipment | 370.00K | 362.90K | 418.10K | 424.00K | 480.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 601.50K | 623.90K | 646.40K | 668.80K | 691.30K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 148.70K | -- | 22.40K | 9.50K |
| Total Assets | 10.33M | 12.28M | 14.57M | 16.12M | 17.95M |
|
|
|||||
| Total Accounts Payable | 599.50K | 483.10K | 401.40K | 215.90K | 230.90K |
| Total Accrued Expenses | 277.60K | 744.50K | 682.20K | 447.60K | 338.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 42.40K | 83.60K | 123.50K |
| Total Finance Division Other Current Liabilities | 3.31M | 2.52M | 3.46M | 4.57M | 2.76M |
| Total Other Current Liabilities | 3.31M | 2.52M | 3.46M | 4.57M | 2.76M |
| Total Current Liabilities | 4.18M | 3.75M | 4.58M | 5.32M | 3.45M |
|
|
|||||
| Total Current Liabilities | 4.18M | 3.75M | 4.58M | 5.32M | 3.45M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.18M | 3.75M | 4.58M | 5.32M | 3.45M |
|
|
|||||
| Common Stock & APIC | 167.15M | 164.20M | 164.02M | 163.74M | 163.41M |
| Retained Earnings | -161.02M | -155.68M | -154.04M | -152.95M | -148.92M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 6.13M | 8.52M | 9.98M | 10.79M | 14.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
|
|
|||||
| Total Common Equity | 6.13M | 8.52M | 9.98M | 10.79M | 14.49M |
| Total Preferred Equity | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.14M | 8.53M | 9.99M | 10.80M | 14.50M |
|
|
|||||